NVCHI
IRWD icon

New Vernon Capital Holdings II’s Ironwood Pharmaceuticals IRWD Stock Holding History

New Vernon Capital Holdings II’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,572
Closed -$141K – 76
2024
Q2 		$141K Sell
21,572
-30,871
-59% -$218K 0.08% 47
2024
Q1 		$457K Hold
52,443
– – 0.24% 43
2023
Q4 		$600K Buy
52,443
+20,738
+65% +$205K 0.32% 35
2023
Q3 		$305K Buy
31,705
+4,837
+18% +$47.4K 0.26% 40
2023
Q2 		$286K Buy
26,868
+5,296
+25% +$56.9K 0.19% 45
2023
Q1 		$227K Buy
21,572
+167
+0.8% +$1.87K 0.17% 44
2022
Q4 		$265K Buy
21,405
+3,476
+19% +$39.4K 0.21% 30
2022
Q3 		$186K Sell
17,929
-13,556
-43% -$154K 0.19% 29
2022
Q2 		$363K Buy
+31,485
New +$371K 0.29% 18

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New Vernon Capital Holdings II's IRWD Position: Q3 2024 in Review

New Vernon Capital Holdings II sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 21,572 shares — an estimated $141K sold.

New Vernon Capital Holdings II first reported a position in IRWD in Q2 2022 and held it in 9 quarters. The position peaked at $600K in Q4 2023. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • New Vernon Capital Holdings II reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • New Vernon Capital Holdings II sold 21,572 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $141K.
  • New Vernon Capital Holdings II first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 9 quarters.
  • New Vernon Capital Holdings II's Ironwood Pharmaceuticals position peaked at $600K in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on New Vernon Capital Holdings II's 13F filing for Q3 2024, filed 14 Nov 2024.